Cytomegalovirus prevalence and transmission after islet allograft transplant in patients with type 1 diabetes mellitus.

Am J Transplant 2004 Oct;4(10):1697-702

Diabetes Research Institute, University of Miami School of Medicine, Miami, FL, USA.

Cytomegalovirus (CMV) serological status of transplant donors and recipients has important implications on antiviral prophylaxis, morbidity/mortality, donor selection and hospital stay. We evaluated CMV prevalence in our islet transplant candidates (ITC) in comparison with organ donors. We correlated the CMV serological status of our ITC with serology for Epstein-Barr virus and Parvovirus B19, auto-antibodies, patient's age, age at DM onset, duration of DM, gender, race, ABO group, HLA haplotype and C-peptide levels. Cytomegalovirus transmission after islet transplant using the Edmonton regimen was also evaluated. Cytomegalovirus seropositivity varied according to patient group, age, gender and race. Type 1 DM patients had reduced odds of CMV seropositivity when compared with organ donors. In all groups studied, older patients, females, and non-Caucasians were more likely to be CMV seropositive. In addition, no CMV reactivation, infection or disease was observed among our transplanted patients using this steroid-free regimen even after donor/recipient CMV mismatch.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-6143.2004.00557.xDOI Listing
October 2004
28 Reads

Publication Analysis

Top Keywords

cmv serological
8
islet transplant
8
serological status
8
gender race
8
transmission islet
8
organ donors
8
cmv
7
age age
4
cytomegalovirus
4
age onset
4
onset duration
4
duration gender
4
females non-caucasians
4
abo group
4
race abo
4
non-caucasians cmv
4
patient's age
4
cmv seropositive
4
cmv reactivation
4
serology epstein-barr
4

References

(Supplied by CrossRef)

Portela D et al.
J Infect Dis 1995

Paya CV et al.
J Hepatol 1993

McCarthy JM et al.
Transplantation 1993

Similar Publications